[Effect of enalapril on clinical and metabolic characteristics in patients with non-insulin-dependent diabetes and arterial hypertension].
Novikov
V I
VI
Miliagina
I V
IV
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000378:metabolism; D004656:Enalapril / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D015227:Lipid Peroxidation; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D014280:Triglycerides; D004656:Enalapril; D002784:Cholesterol
Vliianie énalaprila na kliniko-metabolicheskie pokazateli u bol'nykh insulinnezavisimym diabetom v sochetanii s arterial'noĭ gipertonieĭ.